Journal Article

EURO-NMD registry: federated FAIR infrastructure, innovative technologies and concepts of a patient-centred registry for rare neuromuscular disorders

Toscano, Antonio, Evangelista, Teresinha, Baker, Suzie-Ann, de Visser, Marianne, Kornblum, Cornelia, Horvath, Rita, Sakellariou, Paraskevi, Reviers, Evy, Athanasiou, Dimitrios, D’Angelo, Carla, Blacas, Laura, Jacoupy, Maxime, Atalaia, Antonio, Lalout, Nawel, Lamy, François, Plançon, Jean-Philippe, van der Beek, Nadine, Wilkinson, Mark D., Lochmuller, Hanns, Wandrei, Dagmar, Hoeijmakers, Janneke G. J., Bassez, Guillaume, Paradas, Carmen, Claeys, Kristl G., Hamroun, Dalil, Tassoni, Adrian, Pareyson, Davide, Gyenge, Melinda, Vroom, Elisabeth, Thompson, Rachel, Paliouras, Georgios, Brusse, Esther, t Hoen, Peter A. C., Eng, Catherine, Silani, Vincenzo, Kirschner, Janbernd, Haberlova, Jana, Mancuso, Michelangelo

2024

Overview

Background The EURO-NMD Registry collects data from all neuromuscular patients seen at EURO-NMD's expert centres. In-kind contributions from three patient organisations have ensured that the registry is patient-centred, meaningful, and impactful. The consenting process covers other uses, such as research, cohort finding and trial readiness. Results The registry has three-layered datasets, with European Commission-mandated data elements (EU-CDEs), a set of cross-neuromuscular data elements (NMD-CDEs) and a dataset of disease-specific data elements that function modularly (DS-DEs). The registry captures clinical, neuromuscular imaging, neuromuscular histopathology, biological and genetic data and patient-reported outcomes in a computer-interpretable format using selected ontologies and classifications. The EURO-NMD registry is connected to the EURO-NMD Registry Hub through an interoperability layer. The Hub provides an entry point to other neuromuscular registries that follow the FAIR data stewardship principles and enable GDPR-compliant information exchange. Four national or disease-specific patient registries are interoperable with the EURO-NMD Registry, allowing for federated analysis across these different resources. Conclusions Collectively, the Registry Hub brings together data that are currently siloed and fragmented to improve healthcare and advance research for neuromuscular diseases.

• Publisher: BioMed Central,BioMed Central Ltd,Springer Nature B.V,BMC
• Subject: Clinical outcomes / Clinical trials / Collaboration / Computer Science / Data collection / Data entry / Diagnosis of rare diseases – strategies and structures / Epidemiology / FAIR data / Funding / Genetics / Health care reform / Hospitals / Human Genetics / Humans / Infrastructure (Economics) / Life Sciences / Medical research / Medicine / Medicine & Public Health / Medicine, Experimental / Methods / Neuromuscular Diseases / Neuromuscular Diseases - genetics / Ontology / Other / Patient-centered care / Patients / Pharmacology/Toxicology / Rare Diseases / Registries / Registries (in medicine) / Registry / Registry Hub / Review